TRIP13 antibody
Principal name
TRIP13 antibody
Alternative names for TRIP13 antibody
TRIP-13, 16E1-BP, Thyroid receptor-interacting protein 13, Thyroid hormone receptor interactor 13, Human papillomavirus type 16 E1 protein-binding protein, HPV16 E1 protein-binding protein
Ncbi ID
9606, NP_004228, NP_004228.1, NM_004237, NP_081458.1, NM_027182, NM_001011930, NM_001166260
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of TRIP13 antibody
- Kit Component:
- - KN318251G1, Trip13 gRNA vector 1 in pCas-Guide vector
- KN318251G2, Trip13 gRNA vector 2 in pCas-Guide vector
- KN318251D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Rual,J.F., et al., (2005) Nature 437 (7062), 1173-1178
Detection limit for recombinant GST tagged TRIP13 is approximately 1ng/ml as a capture antibody.
Human Heart; . Rabbit Anti-TRIP13 antibody. . Catalog Number:. ARP35724_T100 . Paraffin Embedded Tissue: Human Heart cell . Cellular Data: Epithelial cells of renal tubule. Antibody Concentration: 4.0-8.0 ug/ml. Magnification: 400X; TRIP13 antibody (ARP35724_T100) in Human Heart cells using Immunohistochemistry
Human Jurkat; WB Suggested Anti-TRIP13 Antibody Titration: 5.0ug/ml. ELISA Titer: 1:12500. Positive Control: Jurkat cell lysate. TRIP13 is supported by BioGPS gene expression data to be expressed in Jurkat.; TRIP13 antibody - N-terminal region (ARP35724_T100) in Human Jurkat cells using Western Blot
Human Lung; . Rabbit Anti-TRIP13 antibody. . Catalog Number:. ARP38434_T100 . Paraffin Embedded Tissue: Human Lung cell . Cellular Data: Epithelial cells of renal tubule. Antibody Concentration: 4.0-8.0 ug/ml. Magnification: 400X; TRIP13 antibody (ARP38434_T100) in Human Lung cells using Immunohistochemistry
Human HepG2; WB Suggested Anti-TRIP13 Antibody Titration: 5.0ug/ml. ELISA Titer: 1:312500. Positive Control: HepG2 cell lysate. TRIP13 is supported by BioGPS gene expression data to be expressed in HepG2.; TRIP13 antibody - C-terminal region (ARP38434_T100) in Human HepG2 cells using Western Blot
Western blot analysis of anti-TRIP13 Antibody (N-term) (Cat.#AP12502PU-N) in 293 cell line lysates (35ug/lane). TRIP13 (arrow) was detected using the purified Pab.
Human HepG2; WB Suggested Anti-TRIP13 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: HepG2 cell lysate. TRIP13 is supported by BioGPS gene expression data to be expressed in HepG2.; TRIP13 antibody - N-terminal region (ARP38433_P050) in Human HepG2 cells using Western Blot
TRIP13 Antibody (C-term) (AP54356PU-N)immunohistochemistry analysis in formalin fixed and paraffin embedded human placenta tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of TRIP13 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Western blot analysis of TRIP13 (arrow) using rabbit polyclonal TRIP13 Antibody (C-term) (AP54356PU-N). 293 cell lysates (2 µg/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the TRIP13 gene.
Immunohistochemical analysis of TRIP13 staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of TRIP13 expression in Jurkat (A); NIH3T3 (B); PC12 (C) whole cell lysates.
Western blot analysis of extracts from LOVO cells and NIH-3T3 cells, using TRIP13 antibody.The lane on the right is treated with the synthesized peptide.
WB Suggested Anti-TRIP13 Antibody Titration: 5.0 ug/ml; ELISA Titer: 1:12500; Positive Control: Jurkat cell lysate TRIP13 is supported by BioGPS gene expression data to be expressed in Jurkat
Rabbit Anti-TRIP13 antibody; Paraffin Embedded Tissue: Human Heart cell; Cellular Data: Epithelial cells of renal tubule; Antibody Concentration: 4.0-8.0 ug/ml; Magnification: 400X
WB Suggested Anti-TRIP13 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 12500; Positive Control: HepG2 cell lysate; TRIP13 is supported by BioGPS gene expression data to be expressed in HepG2
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA314893 | TRIP13 antibody |
||||||
| Rabbit polyclonal anti-TRIP13 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA347670 | TRIP13 antibody |
||||||
| Rabbit Polyclonal Anti-TRIP13 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP12502PU-N | TRIP13 (N-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| AP54356PU-N | TRIP13 (C-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY418122 | TRIP13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204503L2V | Lenti ORF particles, Trip13 (GFP-tagged ORF) - Rat thyroid hormone receptor interactor 13 (Trip13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR204503L1V | Lenti ORF particles, Trip13 (Myc-DDK-tagged ORF) - Rat thyroid hormone receptor interactor 13 (Trip13), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||